LUCKY 18 LTD

Company number 13113682 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

LUCKY 18 LTD - Analysis Report

Company Number: 13113682

Analysis Date: 2025-07-20 13:09 UTC

Financial Health Assessment: LUCKY 18 LTD (as of 31 January 2024)


1. Financial Health Score: C (Moderate Concern)

Explanation:
The company shows a recent turnaround from a serious liquidity crisis in 2023, moving to a positive net current asset position in 2024. However, the very low absolute asset base and small equity suggest a fragile financial state, with risks still present. The score reflects the improvement but cautions that the business is still in a delicate recovery phase.


2. Key Vital Signs

Metric 2024 2023 Interpretation
Current Assets £12,638 £212 Healthy increase in liquid assets; vital sign of improved cash flow or receivables management.
Current Liabilities £7,967 £61,565 Significant reduction in short-term debts; symptom of effective liability management or debt restructuring.
Net Current Assets £4,671 -£61,353 Positive working capital in 2024 vs. large deficit in 2023; indicates better short-term financial health.
Net Assets (Shareholders’ Funds) £4,671 -£61,353 From negative equity to positive suggests recapitalization or retained earnings recovery.
Share Capital £10 £10 Minimal capital base; company is micro-sized with limited equity buffer.
Employees (Average) 6 7 Slight reduction in workforce, possibly cost control measure.

Interpretation of Vital Signs:
The company was previously showing "symptoms of distress" with large current liabilities far exceeding current assets in 2023, indicating liquidity issues and potential insolvency risk. The 2024 figures show a "healthy cash flow" recovery with current assets now exceeding liabilities, enabling better ability to meet short-term obligations. However, the total net assets and equity remain very modest, indicating limited financial cushion.


3. Diagnosis

  • Liquidity and Solvency: The company has moved from a precarious position with significant negative working capital in 2023 to a positive net current asset position in 2024. This is a positive sign akin to a patient recovering from acute distress. The dramatic reduction in current liabilities suggests successful negotiations with creditors, debt repayments, or restructuring.

  • Capital Structure: The minimal share capital (£10) and relatively low net assets (£4,671) mean the company is still vulnerable to financial shocks. There is limited equity to absorb losses or fund growth, much like a patient with low immunity.

  • Operational Scale: As a micro-entity with around 6 employees, the company is small and likely highly sensitive to market changes and operational risks. The slight decrease in staff may represent cost-cutting to stabilize finances.

  • Business Activity: The company operates in varied sectors—unlicensed carrier services, agents in goods sale, and women's outerwear manufacturing—indicating a diversified but possibly unfocused business model which can strain resources.

  • Governance: Two directors are in place, with significant control held by Mr. Jigar Ratilal (75-100%). This concentration of control can be a strength for quick decisions but also a risk if oversight is limited.


4. Recommendations

  • Cash Flow Management: Maintain rigorous monitoring of cash inflows and outflows to ensure liquidity remains positive. Establish cash flow forecasting and contingency reserves to avoid recurrence of past distress symptoms.

  • Debt Management: Continue to manage liabilities prudently. Explore opportunities for refinancing or renegotiating payment terms to sustain the improved working capital.

  • Equity Strengthening: Consider increasing share capital or retaining more earnings to build a stronger equity base, providing a buffer against future losses or economic downturns.

  • Operational Focus: Given the multiple SIC codes, assess the core profitable activities and consider focusing resources on the most viable business lines to improve margins and operational efficiency.

  • Governance and Controls: Implement strong internal controls and perhaps diversify management oversight to reduce risks associated with concentrated control.

  • Growth and Investment: With the improved financial position, cautiously explore growth opportunities but avoid overextending resources or taking on excessive debt.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.